11/5/24 16:46 | 11/4/24 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | S | -120 | 8.68 | 0 | -14 | -1 | 1,064 | D | | | | | | | | | | | | | | |
8/5/24 16:37 | 8/2/24 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | S | -131 | 9.02 | 0 | -14 | -1 | 1,077 | D | | | | | | | | | | | | | | |
5/3/24 16:22 | 5/2/24 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | S | -120 | 8.74 | 0 | -14 | -1 | 1,092 | D | | | | | | | | | | | | | | |
3/6/24 17:09 | 3/4/24 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | S | -166 | 11.12 | 0 | -15 | -1 | 1,106 | D | | | | | | | | | | | | | | |
3/1/24 16:11 | 2/28/24 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | S | -26 | 10.60 | 0 | -2 | 0 | 1,121 | D | | | | | | | | | | | | | | |
12/1/23 20:51 | 12/1/23 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | M.d | 100 | 1.68 | 0 | 60 | 9 | 733 | D | | | | | | | | | | | | | | |
12/1/23 20:51 | 5/31/23 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | P.d | 9 | 6.38 | 0 | 1 | 0 | 733 | D | | | | | | | | | | | | | | |
3/8/23 16:29 | 3/6/23 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | S | -37 | 15.26 | 0 | -2 | 0 | 585 | D | | | | | | | | | | | | | | |
3/2/23 19:06 | 2/28/23 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | S.m | -124 | 15.93 | 0 | -8 | -1 | 587 | D | | | | | | | | | | | | | | |
2/15/23 19:09 | 2/13/23 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | S.m | -17 | 17.01 | 0 | -1 | 0 | 595 | D | | | | | | | | | | | | | | |
2/3/23 16:26 | 2/1/23 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | S | -17 | 17.00 | 0 | -1 | 0 | 596 | D | | | | | | | | | | | | | | |
12/9/22 16:47 | 12/7/22 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | S | -17 | 17.06 | 0 | -1 | 0 | 597 | D | | | | | | | | | | | | | | |
11/9/22 16:39 | 11/7/22 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | S | -18 | 18.00 | 0 | -1 | 0 | 598 | D | | | | | | | | | | | | | | |
10/11/22 18:47 | 10/7/22 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S | -20 | 19.51 | 0 | -1 | 0 | 599 | D | | | | | | | | | | | | | | |
9/9/22 17:10 | 9/7/22 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S | -22 | 21.51 | 0 | -1 | 0 | 600 | D | | | | | | | | | | | | | | |
7/12/22 19:30 | 7/8/22 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -342 | 25.37 | 0 | -14 | -2 | 870 | D | | | | | | | | | | | | | | |
7/12/22 19:30 | 7/8/22 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 12 | 1.68 | 0 | 7 | 1 | 870 | D | | | | | | | | | | | | | | |
7/7/22 16:04 | 7/6/22 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S | -22 | 22.07 | 0 | -1 | 0 | 876 | D | | | | | | | | | | | | | | |
6/6/22 16:06 | 6/6/22 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S | -21 | 21.06 | 0 | -1 | 0 | 877 | D | | | | | | | | | | | | | | |
5/5/22 17:31 | 5/5/22 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S | -22 | 21.76 | 0 | -1 | 0 | 877 | D | | | | | | | | | | | | | | |
4/5/22 18:45 | 4/5/22 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S | -21 | 21.43 | 0 | -1 | 0 | 878 | D | | | | | | | | | | | | | | |
3/11/22 21:42 | 3/9/22 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S | -5 | 17.00 | 0 | 0 | 0 | 879 | D | | | | | | | | | | | | | | |
3/7/22 20:59 | 3/4/22 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.dm | -55 | 16.90 | 0 | -3 | 0 | 879 | D | | | | | | | | | | | | | | |
3/7/22 20:59 | 3/7/22 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 1 | 1.68 | 0 | 1 | 0 | 879 | D | | | | | | | | | | | | | | |
3/3/22 16:18 | 3/1/22 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S | -38 | 17.75 | 0 | -2 | 0 | 811 | D | | | | | | | | | | | | | | |
2/11/22 17:55 | 2/9/22 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 2 | 1.68 | 0 | 1 | 0 | 813 | D | | | | | | | | | | | | | | |
2/11/22 17:55 | 2/9/22 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -17 | 17.00 | 0 | -1 | 0 | 813 | D | | | | | | | | | | | | | | |
1/7/22 16:17 | 1/5/22 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 2 | 1.68 | 0 | 1 | 0 | 813 | D | | | | | | | | | | | | | | |
1/7/22 16:17 | 1/5/22 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -22 | 21.59 | 0 | -1 | 0 | 813 | D | | | | | | | | | | | | | | |
12/10/21 18:41 | 12/8/21 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 2 | 1.68 | 0 | 1 | 0 | 813 | D | | | | | | | | | | | | | | |
12/10/21 18:41 | 12/8/21 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -17 | 17.00 | 0 | -1 | 0 | 813 | D | | | | | | | | | | | | | | |
11/9/21 17:19 | 11/5/21 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 2 | 1.68 | 0 | 1 | 0 | 813 | D | | | | | | | | | | | | | | |
11/9/21 17:19 | 11/5/21 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -22 | 21.50 | 0 | -1 | 0 | 813 | D | | | | | | | | | | | | | | |
10/7/21 16:05 | 10/5/21 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 4 | 1.68 | 0 | 3 | 0 | 813 | D | | | | | | | | | | | | | | |
10/7/21 16:05 | 10/5/21 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -62 | 24.92 | 0 | -3 | 0 | 813 | D | | | | | | | | | | | | | | |
10/5/21 14:10 | 10/1/21 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 3 | 1.68 | 0 | 2 | 0 | 813 | D | | | | | | | | | | | | | | |
10/5/21 14:10 | 10/1/21 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -38 | 25.01 | 0 | -2 | 0 | 813 | D | | | | | | | | | | | | | | |
9/9/21 17:42 | 9/7/21 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 2 | 1.68 | 0 | 1 | 0 | 813 | D | | | | | | | | | | | | | | |
9/9/21 17:42 | 9/7/21 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -21 | 21.14 | 0 | -1 | 0 | 813 | D | | | | | | | | | | | | | | |
8/9/21 18:51 | 8/5/21 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 2 | 1.68 | 0 | 1 | 0 | 813 | D | | | | | | | | | | | | | | |
8/9/21 18:51 | 8/5/21 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -21 | 20.81 | 0 | -1 | 0 | 813 | D | | | | | | | | | | | | | | |
7/8/21 19:40 | 7/6/21 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 3 | 1.68 | 0 | 2 | 0 | 813 | D | | | | | | | | | | | | | | |
7/8/21 19:40 | 7/6/21 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -47 | 26.58 | 0 | -2 | 0 | 813 | D | | | | | | | | | | | | | | |
6/9/21 16:35 | 6/7/21 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 3 | 1.68 | 0 | 2 | 0 | 805 | D | | | | | | | | | | | | | | |
6/9/21 16:35 | 6/7/21 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -46 | 26.35 | 0 | -2 | 0 | 805 | D | | | | | | | | | | | | | | |
5/11/21 11:47 | 5/7/21 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 1 | 1.68 | 0 | 1 | 0 | 804 | D | | | | | | | | | | | | | | |
5/11/21 11:47 | 5/7/21 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -26 | 35.00 | 0 | -1 | 0 | 804 | D | | | | | | | | | | | | | | |
5/7/21 11:29 | 5/5/21 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 3 | 1.68 | 0 | 2 | 0 | 804 | D | | | | | | | | | | | | | | |
5/7/21 11:29 | 5/5/21 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -60 | 34.00 | 0 | -2 | 0 | 804 | D | | | | | | | | | | | | | | |
5/4/21 15:00 | 4/30/21 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S | -53 | 35.00 | 0 | -2 | 0 | 805 | D | | | | | | | | | | | | | | |
4/6/21 17:30 | 4/5/21 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S | -52 | 29.93 | 0 | -2 | 0 | 806 | D | | | | | | | | | | | | | | |
3/5/21 15:56 | 3/5/21 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -53 | 30.55 | 0 | -2 | 0 | 808 | D | | | | | | | | | | | | | | |
3/3/21 16:51 | 3/2/21 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S | -74 | 35.19 | 0 | -2 | 0 | 777 | D | | | | | | | | | | | | | | |
2/8/21 16:00 | 2/5/21 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 17 | 1.68 | 0 | 10 | 1 | 779 | D | | | | | | | | | | | | | | |
2/8/21 16:00 | 2/5/21 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -343 | 34.29 | 0 | -10 | -1 | 779 | D | | | | | | | | | | | | | | |
1/7/21 15:13 | 1/5/21 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.ad | 17 | 1.68 | 0 | 10 | 1 | 779 | D | | | | | | | | | | | | | | |
1/7/21 15:13 | 1/5/21 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.ad | -281 | 28.08 | 0 | -10 | -1 | 779 | D | | | | | | | | | | | | | | |
1/7/21 14:39 | 9/29/20 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 5 | 1.68 | 0 | 3 | 0 | 778 | D | | | | | | | | | | | | | | |
1/7/21 14:39 | 9/29/20 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -90 | 30.00 | 0 | -3 | 0 | 778 | D | | | | | | | | | | | | | | |
10/1/20 21:02 | 9/29/20 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 5 | 1.68 | 0 | 3 | 0 | 778 | D | | | | | | | | | | | | | | |
10/1/20 21:02 | 9/29/20 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -90 | 30.00 | 0 | -3 | 0 | 778 | D | | | | | | | | | | | | | | |
3/16/20 18:05 | 3/13/20 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 100 | 1.68 | 0 | 59 | 8 | 778 | D | | | | | | | | | | | | | | |